SOLFRIZZI, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 16.266
EU - Europa 2.723
AS - Asia 1.022
OC - Oceania 25
AF - Africa 7
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.049
Nazione #
US - Stati Uniti d'America 16.256
CN - Cina 846
SE - Svezia 685
UA - Ucraina 482
DE - Germania 386
IT - Italia 350
FI - Finlandia 279
GB - Regno Unito 168
FR - Francia 132
NL - Olanda 56
VN - Vietnam 56
IE - Irlanda 53
IN - India 51
RU - Federazione Russa 46
BE - Belgio 29
AU - Australia 23
RO - Romania 18
HK - Hong Kong 16
IR - Iran 12
CA - Canada 10
SG - Singapore 9
GR - Grecia 8
JP - Giappone 7
ES - Italia 5
TH - Thailandia 5
AL - Albania 4
PL - Polonia 4
KZ - Kazakistan 3
AT - Austria 2
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LU - Lussemburgo 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
TR - Turchia 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BR - Brasile 1
CO - Colombia 1
HR - Croazia 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
RS - Serbia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 20.049
Città #
Fairfield 2.579
Woodbridge 2.048
Houston 1.374
Chandler 1.265
Ashburn 1.229
Jacksonville 1.117
Seattle 1.103
Ann Arbor 890
Cambridge 860
Wilmington 785
Nyköping 555
Roxbury 296
Lawrence 295
Nanjing 288
Des Moines 205
Beijing 192
Boardman 127
New York 119
Princeton 112
San Diego 95
Bari 90
Nanchang 68
Brooklyn 65
Shenyang 62
Inglewood 61
Hebei 56
Dearborn 55
Dublin 51
Jiaxing 48
Paris 42
Strasbourg 39
Dong Ket 38
Ostuni 36
Changsha 35
Tianjin 35
Pune 34
Ruvo Di Puglia 32
Brussels 29
London 29
Washington 27
Redwood City 25
Los Angeles 23
San Mateo 19
Norwalk 18
Chanh Hiep 16
Helsinki 16
Auburn Hills 13
Falls Church 13
Leawood 13
Redmond 13
San Francisco 13
Scottsdale 12
Taranto 12
Groningen 11
Augusta 10
Ardabil 9
Guangzhou 9
Melbourne 9
Henderson 8
Hong Kong 8
Kilburn 8
Sydney 8
Hefei 7
Ningbo 7
Foggia 6
Rome 6
San Genesio Ed Uniti 6
San Jose 6
Acton 5
Bangkok 5
Canberra 5
Central 5
Monmouth Junction 5
Prescot 5
Toronto 5
Zhengzhou 5
Amsterdam 4
Chiswick 4
Haikou 4
Milan 4
Moscow 4
New Bedfont 4
Phoenix 4
Singapore 4
Tübingen 4
Xian 4
Buffalo 3
Chicago 3
Corfu 3
Cutrofiano 3
Detroit 3
Hanover 3
Madrid 3
Padova 3
Saint Petersburg 3
Santa Clara 3
Santa Marinella 3
Simi Valley 3
Tonbridge 3
University Of Richmond 3
Totale 16.912
Nome #
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 256
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 186
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 164
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 164
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 155
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 142
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 138
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 133
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 127
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 124
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 123
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 121
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 114
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. 110
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 109
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 107
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 107
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 105
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 105
Vascular risk factors, alcohol intake, and cognitive decline 104
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 104
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 103
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia 102
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 102
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 101
Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia 100
Aluminium in the diet, cognitive decline and dementia. 100
Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome 100
All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a) 99
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 99
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 98
Age-related changes of serum N-acetyl-aspartate in healthy controls. 98
Epidemiology of age related hearing loss: A review 98
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 98
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 98
Cognitive frailty: Predementia syndrome and vascular risk factors 97
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment 96
Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia 95
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease 95
S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease 94
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 94
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy 93
Cognitive frailty: a potential target for secondary prevention of dementia 93
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 93
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 92
Mediterranean diet and cognitive decline 91
Assessment of sense of taste in Italian centenarians 91
Metabolic syndrome, mild cognitive impairment, and dementia 90
A rehabilitation program for mild memory impairments. 90
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. 90
Analysis of some aspects of learning and memorization processes in an adult population. 90
Postural and Balance Disorders in Patients with Parkinson's Disease: A Prospective Open-Label Feasibility Study with Two Months of Action Observation Treatment 90
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 90
Dietary unsaturated fatty acids and risk of mild cognitive impairment 89
Nutritional factors, cognitive decline, and dementia 88
Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians 88
Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia 88
CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia 87
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 87
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease 87
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 86
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 86
Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: A systematic review and meta-analysis of individual participant data 86
Impact of aging on the relationships between impairment of "Orientation" and "Recall" items of MMSE and mild to moderate mood disorders. 85
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study 85
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys 85
Current epidemiology of mild cognitive impairment and other predementia syndromes2 84
Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging 84
Mediterranean diet, mild cognitive impairment, and Alzheimer's disease 84
Adherence to a Mediterranean dietary pattern and risk of Alzheimer's disease [7] 84
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 84
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries 84
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease 83
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 83
Alcohol consumption, mild cognitive impairment, and progression to dementia 83
Analysis of individual items of mini-mental state examination in discrimination between normal and demented subjects 82
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 82
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants 82
Dietary fatty acids, age-related cognitive decline and mild cognitive impairment 82
Molecular determinants of human longevity 81
Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe 81
Vascular risk factors, incidence of MCI, and rates of progression to dementia 81
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease 81
Vascular risk and genetics of sporadic late-onset Alzheimer's disease 80
Association Analysis of GRIN2B, Encoding N-Methyl-D-Aspartate Receptor 2B Subunit, and Alzheimer's Disease 80
Mediterranean diet in predementia and dementia syndromes 80
Alcohol Consumption in Predementia and Dementia Syndromes 80
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? 80
Plant-based nutraceutical interventions against cognitive impairment and dementia: Meta-analytic evidence of efficacy of a standardized Gingko biloba extract 80
Dietary intake of unsaturated fatty acids and age-related cognitive decline: A 8.5-year follow-up of the Italian Longitudinal Study on Aging 79
N-3 polyunsaturated fatty acids and statins in heart failure 79
Lipoproteins, vascular-related genetic factors, and human longevity 79
Moderate alcohol consumption, apolipoprotein E, and neuroprotection 79
Progression to dementia in probable and possible mild cognitive impairment 79
Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging 78
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 78
Dietary patterns, foods, and food groups: Relation to late-life cognitive disorders 78
Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia 78
Monounsaturated fatty acids and neuroprotection. The results of a study of cognitive decline in old age. Is there a case for this treatment in multiple sclerosis? 77
Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe 77
Totale 9.731
Categoria #
all - tutte 67.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.103 0 0 0 0 0 0 0 0 0 402 888 813
2019/20206.088 964 372 209 592 679 413 616 567 743 287 503 143
2020/20213.569 310 225 294 454 416 278 283 202 281 456 192 178
2021/20221.843 64 165 12 67 102 184 71 88 154 135 320 481
2022/20233.182 510 303 215 307 379 409 35 371 493 20 81 59
2023/20241.003 106 193 76 73 94 254 56 65 39 47 0 0
Totale 20.729